| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.14 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |